DNA Share Price Performance
₪1.08
0.21 (24.08%)
Price ₪1.08
Share Price₪1.08
Dna Group (T.R.)'s (TLV:DNA) Earnings Are Built On Soft Foundations
Mar 20
Dna Group (T.R.) Ltd Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
DNA Community Narratives
There are no narratives available yet.
Recent DNA News & Updates
Dna Group (T.R.) Ltd Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.0042
- Gross Margin
- 100.00%
- Net Profit Margin
- 168.63%
- Debt/Equity Ratio
- 0%
Dna Group (T.R.) Ltd Competitors
Snowflake Analysis
About DNA
- Founded
- 2004
- Employees
- n/a
- CEO
- Website
Dna Group (T.R.) Ltd, together with its subsidiaries, engages in the development, manufacturing, and marketing of patented ultrasound systems in Israel, North America, East Asia, and internationally. It provides systems for diagnosing bone strength and density, as well as for monitoring calcium leakage (osteoporosis) in adults and children. The company offers its products for use by skilled physicians, nurses, and operators in hospitals and clinics, as well as in pharmacies and other places. In addition, it engages in the development of oral drugs. The company was formerly known as D.N.A Biomedical Solutions Ltd. and changed its name to Dna Group (T.R.) Ltd in November 2022. Dna Group (T.R.) Ltd was incorporated in 2004 and is based in Tel Aviv-Yafo, Israel.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Israeli Market Performance
- 7 Days: 0.3%
- 3 Months: 1.1%
- 1 Year: 59.6%
- Year to Date: 32.2%
The market has been flat over the last week. Meanwhile, the market is actually up 60% over the past year. As for the next few years, earnings are expected to grow by 16% per annum. Market details ›